CompletedPHASE1, PHASE2NCT01789320

Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis

Studying Anterior uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Clearside Biomedical, Inc.
Principal Investigator
Thomas Ciulla, MD
Clearside Biomedical, Inc.
Intervention
triamcinolone acetonide (Triesence®)(drug)
Enrollment
11 enrolled
Eligibility
18 years · All sexes
Timeline
20132015

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01789320 on ClinicalTrials.gov

Other trials for Anterior uveitis

Additional recruiting or active studies for the same condition.

See all trials for Anterior uveitis

← Back to all trials